BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 18783531)

  • 61. Which Postmenopausal Women Should Use Testosterone for Low Sexual Desire?
    Slomski A
    JAMA; 2020 Feb; 323(6):493-495. PubMed ID: 31968073
    [No Abstract]   [Full Text] [Related]  

  • 62. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
    Schover LR
    Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data.
    Islam RM; Bell RJ; Green S; Page MJ; Davis SR
    Lancet Diabetes Endocrinol; 2019 Oct; 7(10):754-766. PubMed ID: 31353194
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.
    Warnock JK; Bundren JC; Morris DW
    Psychopharmacol Bull; 1997; 33(4):761-6. PubMed ID: 9493489
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A clinical update on female androgen insufficiency--testosterone testing and treatment in women presenting with low sexual desire.
    Burger HG; Papalia MA
    Sex Health; 2006 May; 3(2):73-8. PubMed ID: 16800391
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Testosterone for midlife women: the hormone of desire?
    Shifren JL
    Menopause; 2015 Oct; 22(10):1147-9. PubMed ID: 26397145
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacological therapy for female sexual dysfunction: has progress been made?
    Davis SR; Nijland EA
    Drugs; 2008; 68(3):259-64. PubMed ID: 18257605
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder.
    Symonds T; Spino C; Sisson M; Soni P; Martin M; Gunter L; Patrick DL
    J Sex Med; 2007 Sep; 4(5):1328-35. PubMed ID: 17727352
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Genital and subjective measurement of the time course effects of an acute dose of testosterone vs. placebo in postmenopausal women.
    Heard-Davison A; Heiman JR; Kuffel S
    J Sex Med; 2007 Jan; 4(1):209-217. PubMed ID: 17233787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Androgens in postmenopausal women: a review.
    Shifren JL; Davis SR
    Menopause; 2017 Aug; 24(8):970-979. PubMed ID: 28609390
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
    El-Hage G; Eden JA; Manga RZ
    Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Androgen Therapy in Women.
    Vegunta S; Kling JM; Kapoor E
    J Womens Health (Larchmt); 2020 Jan; 29(1):57-64. PubMed ID: 31687883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Female androgen insufficiency.
    Bachmann G; Oza D
    Obstet Gynecol Clin North Am; 2006 Dec; 33(4):589-98. PubMed ID: 17116503
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Testosterone therapy: is it for women? Some try testosterone to boost a sagging libido, but this therapy is still unproven in women.
    Harv Womens Health Watch; 2013 Apr; 20(8):6-7. PubMed ID: 23885375
    [No Abstract]   [Full Text] [Related]  

  • 75. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
    Diamond LE; Earle DC; Heiman JR; Rosen RC; Perelman MA; Harning R
    J Sex Med; 2006 Jul; 3(4):628-638. PubMed ID: 16839319
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Regulatory perspective on clinical trials and end points for female sexual dysfunction, in particular, hypoactive sexual desire disorder: formulating recommendations in an environment of evolving clinical science.
    Shames D; Monroe SE; Davis D; Soule L
    Int J Impot Res; 2007; 19(1):30-6. PubMed ID: 16728969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism.
    Weiss RV; Hohl A; Athayde A; Pardini D; Gomes L; Oliveira M; Meirelles R; Clapauch R; Spritzer PM
    Arch Endocrinol Metab; 2019 Jul; 63(3):190-198. PubMed ID: 31340240
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical Inquiry: which treatments help women with reduced libido?
    Hobbs K; Handler L
    J Fam Pract; 2013 Feb; 62(2):102-3. PubMed ID: 23405381
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Testosterone therapy in female hypoactive sexual desire disorder].
    Meyer P
    Rev Med Suisse; 2016 Mar; 12(510):540-3. PubMed ID: 27149714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.